Literature DB >> 20385332

Color Doppler imaging of retinal diseases.

Galina Dimitrova1, Satoshi Kato.   

Abstract

Color Doppler imaging (CDI) is a widely used method for evaluating ocular circulation that has been used in a number of studies on retinal diseases. CDI assesses blood velocity parameters by using ultrasound waves. In ophthalmology, these assessments are mainly performed on the retrobulbar blood vessels: the ophthalmic, the central retinal, and the short posterior ciliary arteries. In this review, we discuss CDI use for the assessment of retinal diseases classified into the following: vascular diseases, degenerations, dystrophies, and detachment. The retinal vascular diseases that have been investigated by CDI include diabetic retinopathy, retinal vein occlusions, retinal artery occlusions, ocular ischemic conditions, and retinopathy of prematurity. Degenerations and dystrophies included in this review are age-related macular degeneration, myopia, and retinitis pigmentosa. CDI has been used for the differential diagnosis of retinal detachment, as well as the evaluation of retrobulbar circulation in this condition. CDI is valuable for research and is a potentially useful diagnostic tool in the clinical setting.

Entities:  

Mesh:

Year:  2010        PMID: 20385332     DOI: 10.1016/j.survophthal.2009.06.010

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  26 in total

1.  Role of B-scan ocular ultrasound as an adjuvant for the clinical assessment of eyeball diseases: a pictorial essay.

Authors:  Gerardo Dessì; Eduardo Ferrer Lahuerta; Fabrizio Giorgio Puce; Luis Humberto Ros Mendoza; Teseo Stefanini; Ilan Rosenberg; Alberto Del Prato; Michela Perinetti; Alessandro Villa
Journal:  J Ultrasound       Date:  2014-12-30

2.  Update on imaging techniques in oculoplastics.

Authors:  Altug Cetinkaya
Journal:  Saudi J Ophthalmol       Date:  2012-10

3.  Colour Doppler Imaging of Ophthalmic Artery and Central Retinal Artery in Glaucoma Patients with and without Diabetes Mellitus.

Authors:  K Srikanth; M Ashok Kumar; S Selvasundari; M L Prakash
Journal:  J Clin Diagn Res       Date:  2014-04-15

4.  The role of lipid dysregulation and vascular risk factors in glaucomatous retrobulbar circulation.

Authors:  Monika Modrzejewska; Wilhelm Grzesiak; Daniel Zaborski; Anna Modrzejewska
Journal:  Bosn J Basic Med Sci       Date:  2015-03-15       Impact factor: 3.363

5.  Blood flow assessed by color Doppler imaging in retinopathy of prematurity.

Authors:  S Hartenstein; B Müller; B Metze; C Czernik; C Bührer
Journal:  J Perinatol       Date:  2015-05-07       Impact factor: 2.521

6.  Bilateral optic neuropathy in a patient with familial amyloidotic polyneuropathy.

Authors:  Steffen Hamann; Peter Koch Jensen; Hans Callø Fledelius
Journal:  BMJ Case Rep       Date:  2013-09-07

7.  Assessment of orbital blood flow velocities in retinopathy of prematurity.

Authors:  Pehmen Yasin Ozcan; Ferit Dogan; Kenan Sonmez; Rahim Con; Dilek Sen Dokumaci; Eyüp Sabri Seyhanli
Journal:  Int Ophthalmol       Date:  2016-09-03       Impact factor: 2.031

8.  Effect of Methyl-CpG binding domain protein 2 (MBD2) on AMD-like lesions in ApoE-deficient mice.

Authors:  Jun-Ru Pan; Chen Wang; Qi-Lin Yu; Shu Zhang; Bin Li; Jun Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

9.  Segmental reproducibility of retinal blood flow velocity measurements using retinal function imager.

Authors:  Jay Chhablani; Dirk-Uwe Bartsch; Lingyun Cheng; Laura Gomez; Rayan A Alshareef; Sami S Rezeq; Sunir J Garg; Zvia Burgansky-Eliash; William R Freeman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-23       Impact factor: 3.117

10.  Retrobulbar hemodynamic effects of nipradilol in normal and normal-tension glaucoma eyes.

Authors:  Mitsushi Fukukita; Masashi Ido; Syunsuke Osawa; Mikio Sasoh; Motoyasu Furuta; Kunio Ito; Masahiko Sugimoto; Yukitaka Uji
Journal:  J Ophthalmol       Date:  2011-11-03       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.